Home > Insider Trading > Filing (0001213900-17-012230)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1498382	Delmar Pharmaceuticals Inc.	DMPI	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1495521	Saiid Zarrabian	Suite 720-999 West Broadway Vancouver A1 V5Z 1K5	Interim Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2017-11-14	55,000	$0.82	55,000	No	4	P	Direct
Common Stock	Acquisiton	2017-11-14	5,900	$0.84	5,900	No	4	P	Indirect	By Child

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct
No	4	P	Indirect	By Child

Footnotes

This transaction was executed in multiple trades at prices ranging from $0.8015 to $0.8385. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $0.8298 to $0.84. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.